ReviewMetabolism open2026

HbA1c kinetics as a prognostic marker of ophthalmic risk in GLP-1 receptor agonist therapy.

Angeliki Margoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.